Explore Watchlists Pricing

ROHTO PHARMACEUTICAL CO.,LTD. (4527) Income statement

Market cap

¥548.9B

P/E ratio

15.2x

Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2012/03	2013/03	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Revenue	120,292	129,146	143,822	151,774	167,016	154,599	171,742	183,582	188,327	181,287	199,646	238,664	270,840	308,625	343,725
Revenue growth (%)	-
Cost of revenue	-	-	-	61,395	67,250	63,254	70,746	74,048	74,135	74,326	83,157	101,243	113,554	133,686	151,030
Gross profit	-	-	-	90,379	99,766	91,344	100,996	109,533	114,192	106,960	116,488	137,421	157,285	174,939	192,695
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	77,440	83,543	75,893	81,962	88,812	91,154	83,736	87,139	103,461	117,237	135,999	151,576
Operating income	-	-	-	13,159	15,683	15,451	19,087	20,812	23,085	22,990	29,349	33,959	40,048	38,939	41,118
Income before tax	13,684	14,730	17,100	14,098	15,339	15,964	18,849	18,970	22,735	23,910	29,084	35,568	42,434	40,430	47,971
Pretax margin (%)	11.4	11.4	11.9	9.3	9.2	10.3	11	10.3	12.1	13.2	14.6	14.9	15.7	13.1	14
Provision for income taxes	-	-	-	5,123	5,217	4,738	7,483	6,481	6,448	6,236	6,803	7,860	10,123	11,379	12,404
Effective tax rate (%)	-	-	-
Net income	5,591	5,983	4,232	8,631	9,098	10,013	9,336	9,818	15,410	16,770	21,150	26,429	31,394	31,006	24,883
Earnings per share	69.6	68.78	77.15	76.05	80.04	87.95	81.55	86	135.13	146.78	184.26	115.62	135.61	136.11	151.56
Diluted EPS	69.31	68.49	76.82	75.73	79.7	87.57	81.2	85.66	134.71	146.36	183.73	115.29	135.21	135.44	-
Dividend payout ratio (%)	-	-	-	-	-	-	-	-				-			-
Dividend per share	-	-	-	-	-	-	-	-	26	28	36	-	27	36	46